KKR, a global investment firm, and Namal Nawana, the former CEO of both Smith & Nephew and Alere, formed Sapphiros, a platform to build the next generation of diagnostic technologies. Financial terms were not disclosed. “Over the past several years, we have admired Namal’s strategic and operational talents, as well as his entrepreneurial instincts. We look forward to working together to support innovative diagnostic technologies for the tangible benefit of patients globally,” Ali Satvat, KKR Global Head of Health Care Strategic Growth and Co-Head of Americas Health Care Private Equity.